POZEN Reports Fourth Quarter & Year End 2011 Results – Yahoo Finance

The first candidate is PA32540. It is a coordinated-delivery tablet combining immediate-release omeprazole, a proton pump inhibitor, layered around pH-sensitive aspirin. This novel, patented product is administered orally once a day and will be …

Leave a Reply

Your email address will not be published. Required fields are marked *